BNTX vs. MRNA
Compare and contrast key facts about BioNTech SE (BNTX) and Moderna, Inc. (MRNA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BNTX or MRNA.
Key characteristics
| BNTX | MRNA | |
|---|---|---|
| YTD Return | -16.16% | 8.49% |
| 1Y Return | -24.32% | -21.90% |
| 3Y Return (Ann) | -19.72% | -14.70% |
| Sharpe Ratio | -0.72 | -0.47 |
| Daily Std Dev | 35.21% | 49.86% |
| Max Drawdown | -80.48% | -85.65% |
| Current Drawdown | -79.95% | -77.73% |
Fundamentals
| BNTX | MRNA | |
|---|---|---|
| Market Cap | $20.92B | $38.83B |
| EPS | $4.09 | -$12.33 |
| PE Ratio | 21.22 | 24.73 |
| PEG Ratio | 0.04 | 0.00 |
| Revenue (TTM) | $3.82B | $6.85B |
| Gross Profit (TTM) | $16.07B | $10.55B |
| EBITDA (TTM) | $1.11B | -$3.62B |
Correlation
The correlation between BNTX and MRNA is 0.55, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
BNTX vs. MRNA - Performance Comparison
In the year-to-date period, BNTX achieves a -16.16% return, which is significantly lower than MRNA's 8.49% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BNTX vs. MRNA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Moderna, Inc. (MRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BNTX vs. MRNA - Dividend Comparison
Neither BNTX nor MRNA has paid dividends to shareholders.
| TTM | 2023 | 2022 | |
|---|---|---|---|
BNTX BioNTech SE | 0.00% | 0.00% | 1.41% |
MRNA Moderna, Inc. | 0.00% | 0.00% | 0.00% |
Drawdowns
BNTX vs. MRNA - Drawdown Comparison
The maximum BNTX drawdown since its inception was -80.48%, smaller than the maximum MRNA drawdown of -85.65%. Use the drawdown chart below to compare losses from any high point for BNTX and MRNA. For additional features, visit the drawdowns tool.
Volatility
BNTX vs. MRNA - Volatility Comparison
The current volatility for BioNTech SE (BNTX) is 5.48%, while Moderna, Inc. (MRNA) has a volatility of 12.36%. This indicates that BNTX experiences smaller price fluctuations and is considered to be less risky than MRNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BNTX vs. MRNA - Financials Comparison
This section allows you to compare key financial metrics between BioNTech SE and Moderna, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities